Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
4,017,625
-
Share change
-
-37,315
-
Total reported value
-
$44,513,000
-
Price per share
-
$11.08
-
Number of holders
-
20
-
Value change
-
-$755,139
-
Number of buys
-
7
-
Number of sells
-
5
Institutional Holders of SUMMIT THERAPEUTICS INC COM - Stock (SMMT) as of Q4 2017
As of 31 Dec 2017,
SUMMIT THERAPEUTICS INC COM - Stock (SMMT) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,017,625 shares.
The largest 10 holders included
LANSDOWNE PARTNERS (UK) LLP, Point72 Asset Management, L.P., AXA, Granite Point Capital Management, L.P., SPHERA FUNDS MANAGEMENT LTD., First Eagle Investment Management, LLC, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, Polar Capital LLP, and MILLENNIUM MANAGEMENT LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.